FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,276 letters match. Newest first.
-
DrugsEksa Mills S.A. de C.V.
FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.
High risk -
DrugsLegacy Pharmaceutical Packaging LLC
Legacy Pharmaceutical Packaging, a drug repackager, was cited for CGMP violations and insanitary conditions after foreign tablets and floor-picked tablets were found.
High risk -
DrugsSterling Pharmaceutical Services, LLC
Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.
High risk -
DrugsBespoke Apothecary LLC
Bespoke Apothecary sold COVID kit and herbal tea with unapproved COVID-19 treatment claims, FDA and FTC say.
Low -
DrugsSystem Kosmetik Produktionsgesellschaft fur kosmetische Gmbh
German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.
High risk -
DrugsZhejiang Tianyu Pharmaceutical Co., Ltd.
Zhejiang Tianyu Pharmaceutical made active pharmaceutical ingredients (API) with current good manufacturing practice (CGMP) deviations in impurity investigations and equipment cleaning.
High risk -
DrugsSanitizer Supply LLC
FDA warns Sanitizer Supply LLC that its hand sanitizer wipes and sanitizers lacked required potency and microbial testing before release.
High risk -
DrugsVirgin Scent Inc. dba Artnaturals
FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.
High risk -
DrugsVita Pharmacy, LLC dba Talon Pharmacy of Boerne
FDA warned Talon Pharmacy of Boerne that it made sterile compounded drugs under insanitary conditions that could contaminate them.
High risk -
DrugsEpisciences Inc.
FDA warns Episciences Inc. that its Boise, Idaho plant made OTC drugs without adequate batch testing, process validation and failure investigations.
High risk -
DrugsGreen Wave Analytical, LLC
FDA warned Green Wave Analytical, a contract drug testing lab, over quality violations and its denied inspection access.
High risk -
DrugsGordon Laboratories Inc.
FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.
High risk -
DrugsTramadol US
FDA warned Tramadol US for selling unapproved, misbranded opioid and benzodiazepine drugs, including tramadol, oxymorphone, and alprazolam, over the internet.
High risk -
DrugsCangene BioPharma, LLC dba Emergent BioSolutions
FDA cites Emergent BioSolutions Baltimore plant for CGMP violations after metal particulates and poor aseptic technique in sterile drugs.
High risk -
DrugsVerde Cosmetic Labs LLC
FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.
High risk -
DrugsJB Exchange Inc./Justified Laboratories
JB Exchange/Justified Laboratories sold unapproved skin tag and mole removal serums online, FDA says.
High risk -
DrugsAriella Naturals
FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.
High risk -
DrugsAmazon.com, Inc.
Amazon distributes unapproved new drugs for mole and skin tag removal, FDA says.
High risk -
DrugsFluxxLab LLC
FDA and FTC warned FluxxLab that its COVID-19 and CBDA/CBD tinctures are unapproved, misbranded drugs marketed with unsupported COVID-19 claims.
High risk -
DrugsDSP Skin Care LLC
FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.
High risk -
DrugsJose Miguel Gutierrez Salas
FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.
High risk -
DrugsGuangzhou Orchard Aromatherapy & Skin Care Co., Ltd.
Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.
High risk -
DrugsJost Chemical Co.
Jost Chemical Co. made active drug ingredients under CGMP deviations, including mold contamination and inadequate investigations.
High risk -
DrugsDaniel Fred Goodman, M.D./Goodman Eye Center
FDA warns Dr. Daniel Fred Goodman/Goodman Eye Center over clinical drug study without required FDA application and missing consent/assent.
High risk -
DrugsCustom Research Labs Inc.
FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.
High risk -
DrugsBi-Coastal Pharma International
FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.
High risk -
DrugsBioiberica, SAU
FDA warned Bioiberica over unvalidated rework and missing stability testing of API batches at its Spain plant.
High risk -
DrugsImprimis Rx LLC
FDA warns Imprimis Rx over false, misleading promotion of compounded eye drug Pred-Moxi-Brom.
Low -
DrugsGenlabs Corporation
FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.
High risk -
DrugsElite Supplement Center LLC and Elite Training Facility LLC
FDA warned Elite Supplement Center that it sells five SARM products as unapproved new drugs for human use.
High risk -
DrugsDDI Multinacional S.A. de C.V.
DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.
High risk -
DrugsNoticias Mexico Hoy Grupo Multimedia, S.A. de C.V.
Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.
High risk -
DrugsHerbsens Botanicals
Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.
High risk -
DrugsKlarity Kratom
Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.
High risk -
DrugsKratom Exchange
FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.
High risk -
DrugsOmni Consumer Products LLC d/b/a YoKratom
FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.
High risk -
DrugsMONQ, LLC
MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.
High risk -
DrugsMirfeel Korea Co., Ltd.
Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.
High risk -
DrugsIndustrias Cklass S. de R.L. de C.V.
FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.
High risk -
DrugsFagron Group B.V.
FDA warns Fagron over cleaning and cross-contamination failures in active pharmaceutical ingredient repackaging.
High risk -
DrugsMonarch PCM, LLC
Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.
High risk -
DrugsGlicerinas Industriales, S.A. de C.V.
Glicerinas Industriales refused a pre-announced FDA inspection; FDA calls its glycerin drugs adulterated and placed firm on Import Alert 66-79.
High risk -
DrugsHybrid Pharma, LLC
FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.
High risk -
DrugsSmitha C. Reddy, M.D./ACRC Studies, LLC
FDA warns Dr. Smitha Reddy over clinical trial protocol violations, including wrong drug given and broken blinding.
High risk -
DrugsAire-Master of America, Inc.
FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.
High risk -
DrugsGrimann S.A. de C.V.
FDA warns Grimann over Derofen Miel drug listing with contradictory active ingredients, label image, and package size.
Low -
DrugsNew Vitalis, LLC dba New Vitalis Pharmacy
New Vitalis Pharmacy made sterile compounded drugs under insanitary conditions that risked contamination.
High risk -
DrugsAyuryoga, Inc.
FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.
High risk -
DrugsSanthigram Kerala Ayurvedic Co. of U.S., Inc.
FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.
High risk -
DrugsColorful Products Corporation
FDA warned Colorful Products Corporation about serious current good manufacturing practice (CGMP) failures for its over-the-counter topical drugs and hand sanitizers.
High risk